nitazoxanide has been researched along with Chronic Hepatitis C in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elazar, M; Glenn, JS; Korba, BE; Lui, P; Rossignol, JF | 1 |
| Cahn, P; Gun, A; Laufer, N; Ojeda, D; Quarleri, J; Sede, M | 1 |
| Deraz, DM; Elbaz, TM; Shehab, HM | 1 |
| Gluud, C; Grevstad, B; Jakobsen, JC; Nikolova, K | 1 |
| Ehsan, N; El-Fert, A; El-Said, H; Ezzat, S; Kohla, MA; Taha, H | 1 |
| Delgado, M; López-Cortés, LF; Macías, J; Ojeda-Burgos, G; Pineda, JA; Recio, E; Ríos, MJ; Rivero-Juárez, A; Téllez, F | 1 |
| Amorosa, VK; Dou, D; Kang, M; Kottilil, S; Lee, YJ; Matining, R; Osinusi, A; Peters, MG; Petersen, T; Umbleja, T; Wang, C; Zhang, X | 1 |
| El-Gohary, Y; Elfert, A; Kabil, SM; Keeffe, EB; Rossignol, JF | 1 |
| Keeffe, EB; Rossignol, JF | 2 |
| El-Gohary, Y; Elfert, A; Keeffe, EB; Rossignol, JF | 1 |
| Darling, JM; Fried, MW | 1 |
| Rossignol, JF | 1 |
| Forde, KA; Reddy, KR | 1 |
| Khattab, MA | 1 |
| Elfert, A; Keeffe, EB; Rossignol, JF | 1 |
| Takehara, T | 1 |
| Kabil, SM; Mounier, BI; Soliman, MS; Youssef, SM | 1 |
| Abusamra, L; Bolcic, F; Cahn, P; Gun, A; Krolewiecki, A; Laufer, N; Pérez, H; Quarleri, J; Rolón, MJ; Salomón, H | 1 |
| Hokari, A | 1 |
| El Kassas, M; El Raziky, M; Esmat, G; Gamil, ME; Hassany, M | 1 |
8 review(s) available for nitazoxanide and Chronic Hepatitis C
| Article | Year |
|---|---|
Nitazoxanide for chronic hepatitis C.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Cause of Death; Hepatitis C, Chronic; Humans; Nitro Compounds; Randomized Controlled Trials as Topic; Thiazoles | 2014 |
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.
Topics: Antiviral Agents; Clinical Trials as Topic; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Nitro Compounds; Thiazoles | 2008 |
Thiazolides: a new class of antiviral drugs.
Topics: Antiviral Agents; Clinical Trials as Topic; Gastroenteritis; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Nitro Compounds; Thiazoles | 2009 |
Hepatitis C virus infection and immunomodulatory therapies.
Topics: Antibodies, Monoclonal; Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Immunoglobulins; Immunologic Factors; Immunotherapy; Interferons; Nitro Compounds; Ribavirin; Thiazoles; Toll-Like Receptors; Viral Hepatitis Vaccines | 2009 |
Targeting host factors: a novel rationale for the management of hepatitis C virus.
Topics: Antibodies; Antiviral Agents; Cyclophilins; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Nitro Compounds; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Virus; Thiazoles; Virus Internalization | 2009 |
[Antiviral therapy for chronic hepatitis C: current status and perspectives].
Topics: Antiviral Agents; DNA-Directed RNA Polymerases; Drug Administration Schedule; Drug Discovery; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Nitro Compounds; Oligopeptides; Polyethylene Glycols; Protease Inhibitors; Pyrimidine Nucleosides; Recombinant Proteins; Ribavirin; Thiazoles | 2010 |
[Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
Topics: Antiviral Agents; Cyclosporine; Diterpenes; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fatty Alcohols; Female; Fluvastatin; Hepatitis C, Chronic; Humans; Indoles; Interferon-alpha; Male; Metformin; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Silybin; Silymarin; Thiazoles | 2011 |
The future for the treatment of genotype 4 chronic hepatitis C.
Topics: Albumins; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Nitro Compounds; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Thiazoles; Time Factors; Viral Load; Vitamin D | 2012 |
7 trial(s) available for nitazoxanide and Chronic Hepatitis C
| Article | Year |
|---|---|
Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial.
Topics: Drug Therapy, Combination; Egypt; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Logistic Models; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Statistics, Nonparametric; Thiazoles | 2014 |
Impact of nitazoxanide on sustained virologic response in Egyptian patients with chronic hepatitis C genotype 4: a double-blind placebo-controlled trial.
Topics: Adult; Antiparasitic Agents; Antiviral Agents; Double-Blind Method; Drug Therapy, Combination; Egypt; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thiazoles; Viral Load | 2016 |
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.
Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Nitro Compounds; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thiazoles; Treatment Outcome | 2015 |
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
Topics: Adult; Antiviral Agents; Coinfection; Female; Gene Expression Profiling; Hepatitis C, Chronic; HIV Infections; Humans; Immunologic Factors; Interferon-alpha; Interferons; Leukocytes, Mononuclear; Male; Middle Aged; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiazoles | 2016 |
Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.
Topics: Adult; Aged; Antiviral Agents; Double-Blind Method; Egypt; Female; Genotype; Hepatitis C, Chronic; Humans; Male; Middle Aged; Nitro Compounds; Risk Factors; RNA, Viral; Tablets; Thiazoles; Treatment Outcome | 2008 |
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.
Topics: Adult; Antiparasitic Agents; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiazoles; Treatment Outcome; Young Adult | 2009 |
A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4.
Topics: Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Nitro Compounds; RNA, Viral; Thiazoles | 2011 |
6 other study(ies) available for nitazoxanide and Chronic Hepatitis C
| Article | Year |
|---|---|
Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide.
Topics: Antiviral Agents; Cell Line; Cytidine; Drug Resistance, Viral; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nitro Compounds; Recombinant Proteins; Replicon; Ribavirin; Thiazoles; Virus Replication | 2008 |
Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.
Topics: Amino Acid Sequence; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Molecular Sequence Data; Nitro Compounds; Polyethylene Glycols; Ribavirin; Sequence Alignment; Sequence Analysis, DNA; Thiazoles; Treatment Failure; Viral Nonstructural Proteins | 2013 |
Nitazoxanide: beyond parasites toward a novel agent for hepatitis C.
Topics: Antiparasitic Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Nitro Compounds; Thiazoles | 2009 |
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides.
Topics: Antiparasitic Agents; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Nitro Compounds; Placebos; Thiazoles | 2009 |
Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide.
Topics: Adult; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Nitro Compounds; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiazoles; Time Factors; Treatment Outcome; Young Adult | 2010 |
No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.
Topics: Adult; Antiviral Agents; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Nitro Compounds; Pilot Projects; Thiazoles; Treatment Failure; Viral Load | 2011 |